Finding better ultrasound screening methods for women with dense breasts
Identifying effective risk-based supplemental ultrasound screening strategies for women with dense breasts
This study is looking at whether adding ultrasound screenings can help find breast cancer earlier in women with dense breasts, who are at a higher risk, so that doctors can better guide them on the best screening options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Vermont & St Agric College NIH-funded |
| Lab location | 1 site (Burlington, United States) |
| Project ID | NIH-10795820 on NIH RePORTER |
What this research studies
This research investigates how supplemental ultrasound screening can improve breast cancer detection in women with dense breasts, who are at higher risk for advanced cancer. The study will analyze the effectiveness of these screening methods and their impact on clinical outcomes, such as the rates of advanced cancer diagnoses. By using computer-based simulations and evaluating clinical risk factors, the research aims to develop guidelines that can help healthcare providers make informed decisions about screening options for these women.
Who could benefit from this research
Good fit: Ideal candidates for this research are women aged 40-74 with dense breast tissue who are at increased risk for breast cancer.
Not a fit: Patients who do not have dense breasts or are outside the age range of 40-74 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved screening strategies that enhance early detection of breast cancer in women with dense breasts.
How similar studies have performed: Previous studies have shown promise in using supplemental ultrasound screening for women with dense breasts, but this research aims to provide more definitive guidelines.
Where this research is happening
Burlington, United States
- University of Vermont & St Agric College — Burlington, United States (Active)
Researchers
- Principal investigator: Sprague, Brian L — University of Vermont & St Agric College
- Study coordinator: Sprague, Brian L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.